Abstract
Introduction
The clinical factors predisposing to ischemic stroke in reversible cerebral vasoconstriction syndrome (RCVS) are unclear. In this observational cross-sectional study, we aimed to evaluate the risk factors and clinical outcomes associated with the development of ischemic stroke in patients with RCVS.
Methods
We utilized the Nationwide Readmissions Database 2016–2017 to identify all hospitalizations with RCVS, with or without acute ischemic stroke. Independent predictors of and clinical outcomes associated with ischemic stroke were analyzed using logistic regression.
Results
Among 1065 hospitalizations for RCVS (mean ± SD age 49.0 ± 16.7 years, female 69.7%), 267 (25.1%) had ischemic stroke. Patients with ischemic stroke were more likely to have hypertension (OR 2.33, 95% CI 1.51–3.60), diabetes (OR 1.81, 95% CI 1.11–2.98), and tobacco use (OR 1.64, 95% CI 1.16–2.33) and were less likely to have a history of migraine (OR 0.56, 95% CI 0.35–0.90). Ischemic stroke was associated with higher odds of cerebral edema (OR 3.15, 95% CI 1.31–7.57) and respiratory failure (OR 2.39, 95% CI 1.28–4.44). Patients with ischemic stroke also had longer hospital stay by a mean duration of 6.7 days, P < 0.001, higher hospital charges by a mean of $72,961, P < 0.001, and a higher likelihood of not being discharged to home (OR 3.57, 95% CI 2.39–5.33). They had higher in-hospital mortality rate; however, the difference was not statistically significant.
Conclusion
Ischemic stroke affects nearly 25% of patients with RCVS and is associated with adverse clinical outcomes. RCVS patients with cerebrovascular risk factors might have a higher predisposition for developing ischemic lesions during the disease process.
Similar content being viewed by others
Data availability
The Nationwide Readmissions Database is a publicly available dataset that can be obtained after completion of the HCUP data use agreement.
References
Ducros A, Bousser MG (2009) Reversible cerebral vasoconstriction syndrome. Pract Neurol 9(5):256–267. https://doi.org/10.1136/jnnp.2009.187856
Ducros A (2012) Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11(10):906–917. https://doi.org/10.1016/s1474-4422(12)70135-7
Singhal AB, Hajj-Ali RA, Topcuoglu MA, Fok J, Bena J, Yang D, Calabrese LH (2011) Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 68(8):1005–1012. https://doi.org/10.1001/archneurol.2011.68
Katz BS, Fugate JE, Ameriso SF, Pujol-Lereis VA, Mandrekar J, Flemming KD, Kallmes DF, Rabinstein AA (2014) Clinical worsening in reversible cerebral vasoconstriction syndrome. JAMA Neurol 71(1):68–73. https://doi.org/10.1001/jamaneurol.2013.4639
Garg A, Rocha M, Starr M, Ortega-Gutierrez S (2021) Predictors and outcomes of hemorrhagic stroke in reversible cerebral vasoconstriction syndrome. J Neurol Sci 421:117312. https://doi.org/10.1016/j.jns.2021.117312
Topcuoglu MA, Singhal AB (2016) Hemorrhagic reversible cerebral vasoconstriction syndrome: features and mechanisms. Stroke 47(7):1742–1747. https://doi.org/10.1161/STROKEAHA.116.013136
Overview N (December 2019) Healthcare Cost and Utilization Project (HCUP).
Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130(12):3091–3101. https://doi.org/10.1093/brain/awm256
Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG (2010) Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 41(11):2505–2511. https://doi.org/10.1161/STROKEAHA.109.572313
Banerjee C, Chimowitz MI (2017) Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res 120(3):502–513
Ruland S, Aiyagari V (2007) Cerebral autoregulation and blood pressure lowering. Am Heart Assoc 10:13–34
Fabjan A, Zaletel M, Žvan B (2015) Is there a persistent dysfunction of neurovascular coupling in migraine? Biomed Res Int 2:574186. https://doi.org/10.1155/2015/574186
Magid-Bernstein J, Salehi Omran S, Murthy SB, Merkler AE, Kamel H (2020) Abstract WP228: reversible cerebral vasoconstriction syndrome: presenting symptoms, incidence, and outcomes in a multi-state cohort in the USA. Stroke 51(1):AWP228–AWP228
Funding
None.
Author information
Authors and Affiliations
Contributions
All authors were involved in the conception of the study design. Statistical analysis was performed by AG. The first draft of the manuscript was written by AG and SO-G. All authors were involved in the critical revision of the manuscript. All authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethics approval
The study was exempt from the Institutional Review Board as we used a publicly available database with deidentified information.
Rights and permissions
About this article
Cite this article
Garg, A., Starr, M., Rocha, M. et al. Predictors and outcomes of ischemic stroke in reversible cerebral vasoconstriction syndrome. J Neurol 268, 3020–3025 (2021). https://doi.org/10.1007/s00415-021-10456-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-021-10456-2